C07D 307/86
With an oxygen atom directly attached in position 7
Official title: with an oxygen atom directly attached in position 7
C07D307/86 (With an oxygen atom directly attached in position 7) appears on 269 US grants and 87 published applications in this corpus.
Search patents in C07D- Granted patents
- 269
- Published applications
- 87
- Assignees
- 121
- Inventors
- 600
- Latest grant
- 12 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 10 | 0 |
| 1977 | 6 | 0 |
| 1978 | 12 | 0 |
| 1979 | 6 | 0 |
| 1980 | 7 | 0 |
| 1981 | 26 | 0 |
| 1982 | 16 | 0 |
| 1983 | 16 | 0 |
| 1984 | 11 | 0 |
| 1985 | 16 | 0 |
| 1986 | 17 | 0 |
| 1987 | 11 | 0 |
| 1988 | 8 | 0 |
| 1989 | 8 | 0 |
| 1990 | 4 | 0 |
| 1991 | 4 | 0 |
| 1992 | 4 | 0 |
| 1993 | 4 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 6 | 0 |
| 1999 | 4 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 4 |
| 2003 | 2 | 2 |
| 2004 | 2 | 6 |
| 2005 | 1 | 3 |
| 2006 | 6 | 8 |
| 2007 | 5 | 6 |
| 2008 | 3 | 7 |
| 2009 | 6 | 4 |
| 2010 | 3 | 5 |
| 2011 | 3 | 2 |
| 2012 | 2 | 4 |
| 2013 | 1 | 6 |
| 2014 | 4 | 3 |
| 2015 | 2 | 2 |
| 2016 | 2 | 4 |
| 2017 | 2 | 3 |
| 2018 | 4 | 1 |
| 2019 | 2 | 5 |
| 2020 | 3 | 1 |
| 2021 | 3 | 5 |
| 2022 | 2 | 1 |
| 2023 | 1 | 1 |
| 2024 | 0 | 1 |
| 2025 | 2 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for treating triple negative breast cancer using salvianolic acid B12 Aug 2025US 12,383,527 B2Howard University
- Carboxamides as modulators of sodium channels22 Apr 2025US 12,281,057 B2Vertex Pharmaceuticals Incorporated
- Carboxamides as modulators of sodium channels14 Mar 2023US 11,603,351 B2Vertex Pharmaceuticals Incorporated
- α,β-unsaturated amide compound20 Sep 2022US 11,447,471 B2Kyowa Kirin Co., Ltd.
- Therapeutic aurones29 Mar 2022US 11,286,245 B2Middle Tennessee State University
- 3-aryloxy-3-aryl-propylamine compound and uses thereof20 Aug 2026US 2026/0242364 A1Shanghai Leado Pharmatech Co. Ltd.
- Parthenolide derivatives and use thereof19 Jun 2025US 2025/0197416 A1University of Rochester
- Modulators of molecular targets expressed in metabolic and inflammatory disorders9 Jan 2025US 2025/0011296 A1Ohio State Innovation Foundation
- Methods for treating triple negative breast cancer using salvianolic acid b6 Jun 2024US 2024/0180867 A1Howard University
- Carboxamides as modulators of sodium channels14 Sep 2023US 2023/0286907 A1Vertex Pharmaceuticals Incorporated
Most cited
By later US patents
- Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them57US 5,852,046 AHoechst Aktiengesellschaft · 1998
- N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives56US 7,176,242 B2Elan Pharmaceuticals, Inc. · 2007
- Fused bicyclic amide compounds and medicinal use thereof41US 7,112,594 B2Mitsubishi Pharma Corporation · 2006
- Insecticidal bicyclooxyphenyl ureas35US 4,426,385 AUnion Carbide Corporation · 1984
- Hybrid 1,3-dione-carbamate compounds28US 4,303,669 AUnion Carbide Corporation · 1981